Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Adaptimmune Therapeutics PLC
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-01-18
Sale
2022-01-18
9:04 pm
Adaptimmune Therapeutics PLC ADAP Bertrand William C JR
Chief Operating Officer
4,368 $3.1918 $13,942 7,336
(Direct)
View
2022-01-18
Sale
2022-01-18
9:03 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
4,368 $3.1918 $13,942 7,336
(Direct)
View
2022-01-18
Sale
2022-01-18
9:02 pm
Adaptimmune Therapeutics PLC ADAP Norry Elliot
Chief Medical Officer
2,121 $3.1918 $6,770 3,529
(Direct)
View
2022-01-18
Sale
2022-01-18
9:00 pm
Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
CEO
11,096 $3.1918 $35,416 12,312
(Direct)
View
2022-01-11
Sale
2022-01-13
9:02 pm
Adaptimmune Therapeutics PLC ADAP Bertrand William C JR
Chief Operating Officer
6,018 $3.552 $21,376 3,754
(Direct)
View
2022-01-11
Sale
2022-01-13
9:02 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
4,846 $3.5539 $17,222 1,749
(Direct)
View
2022-01-11
Sale
2022-01-13
9:01 pm
Adaptimmune Therapeutics PLC ADAP Norry Elliot
Chief Medical Officer
4,624 $3.5544 $16,435 1,383
(Direct)
View
2022-01-11
Sale
2022-01-13
9:01 pm
Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
CEO
17,408 $3.5545 $61,877 3,356
(Direct)
View
2022-01-04
Sale
2022-01-05
9:08 pm
Adaptimmune Therapeutics PLC ADAP Bertrand William C JR
Chief Operating Officer
3,490 $4.0642 $14,184 5,873
(Direct)
View
2022-01-04
Sale
2022-01-05
9:06 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,070 $4.0642 $4,349 1,755
(Direct)
View
2022-01-04
Sale
2022-01-05
9:05 pm
Adaptimmune Therapeutics PLC ADAP Norry Elliot
Chief Medical Officer
849 $4.0642 $3,451 1,388
(Direct)
View
2022-01-04
Sale
2022-01-05
9:04 pm
Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
CEO
5,532 $4.0642 $22,483 6,172
(Direct)
View
2021-09-01
Sale
2021-09-01
9:00 pm
Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
CEO
2,782 $5.195 $14,452 3,070
(Direct)
View
2021-08-02
Sale
2021-08-02
5:09 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
2,939 $3.5848 $10,536 4,873
(Direct)
View
2021-07-02
Sale
2021-07-02
8:01 pm
Adaptimmune Therapeutics PLC ADAP Bertrand William C JR
Chief Operating Officer
4,375 $4.2649 $18,659 7,329
(Direct)
View
2021-07-02
Sale
2021-07-02
8:01 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,907 $4.2649 $8,133 3,170
(Direct)
View
2021-06-28
Sale
2021-06-28
9:01 pm
Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
CEO
2,794 $4.37 $12,210 3,058
(Direct)
View
2021-06-01
Purchase
2021-06-03
4:31 pm
Adaptimmune Therapeutics PLC ADAP Alleva Lawrence M
Director
12,600 $0.79 $9,954 143,364
(Indirect
Direct)
View
2021-01-19
Sale
2021-01-19
9:01 pm
Adaptimmune Therapeutics PLC ADAP Norry Elliot
Chief Medical Officer
2,111 $5.6695 $11,968 3,539
(Direct)
View
2021-01-19
Sale
2021-01-19
9:01 pm
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
4,358 $5.6695 $24,708 7,346
(Direct)
View
2021-01-19
Sale
2021-01-19
9:00 pm
Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
CEO
9,879 $5.6695 $56,009 13,529
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-05-04
Option Award
2022-05-04
9:03 pm
N/A
2032-05-04
Adaptimmune Therapeutics PLC ADAP Brewer Joanna Elizabeth
Chief Scientific Officer
557,304 $0 557,304
(Direct)
View
2022-01-31
Option Award
2022-01-31
9:05 pm
N/A
2032-01-31
Adaptimmune Therapeutics PLC ADAP Piccina Cintia
Chief Commercial Officer
4,466,376 $0 4,466,376
(Direct)
View
2022-01-12
Option Award
2022-01-13
9:04 pm
N/A
2032-01-12
Adaptimmune Therapeutics PLC ADAP Lunger John
Chief Patient Supply Officer
1,721,328 $0 1,721,328
(Direct)
View
2022-01-12
Option Award
2022-01-13
9:03 pm
N/A
2032-01-12
Adaptimmune Therapeutics PLC ADAP TAYTON-MARTIN HELEN KATRINA
Chief Business Officer
1,721,328 $0 1,721,328
(Direct)
View
2022-01-12
Option Award
2022-01-13
9:03 pm
N/A
2032-01-12
Adaptimmune Therapeutics PLC ADAP Wood Gavin
CFO
1,721,328 $0 1,721,328
(Direct)
View
2022-01-12
Option Award
2022-01-13
9:02 pm
N/A
2032-01-12
Adaptimmune Therapeutics PLC ADAP Norry Elliot
Chief Medical Officer
2,581,968 $0 2,581,968
(Direct)
View
2022-01-12
Option Award
2022-01-13
9:00 pm
N/A
2032-01-12
Adaptimmune Therapeutics PLC ADAP Bertrand William C JR
Chief Operating Officer
1,721,328 $0 1,721,328
(Direct)
View
2022-01-12
Option Award
2022-01-13
9:00 pm
N/A
2032-01-12
Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
CEO
5,737,704 $0 5,737,704
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:03 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLC ADAP Zaks Tal Zvi
Director
379,788 $0 379,788
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:03 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLC ADAP Alleva Lawrence M
Director
505,918 $0 505,918
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:03 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLC ADAP Furey John
Director
379,788 $0 379,788
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:02 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLC ADAP Noble James
Director
379,788 $0 379,788
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:01 pm
2022-07-01
2031-07-02
Adaptimmune Therapeutics PLC ADAP Sigal Charles Elliott
Director
474,385 $0 474,385
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:01 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLC ADAP MOTT DAVID M
Director
579,494 $0 579,494
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:01 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLC ADAP Behbahani Ali
Director
474,385 $0 474,385
(Direct)
View
2021-07-01
Option Award
2021-07-02
5:00 pm
2022-07-01
2031-07-01
Adaptimmune Therapeutics PLC ADAP Duncan Barbara Gayle
Director
379,788 $0 379,788
(Direct)
View
2021-03-03
Exercise
2021-03-03
9:01 pm
N/A
N/A
Adaptimmune Therapeutics PLC ADAP TAYTON-MARTIN HELEN KATRINA
Chief Business Officer
1,785,000 $0.157 1,800,000
(Direct)
View
Goto 0, 1, 2, 3, 4, Next